PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.20%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-23.01%
Cost reduction while CRK shows 83.87% growth. Joel Greenblatt would examine competitive advantage.
21.97%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
23.45%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.11%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
-0.35%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-15.95%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
-1.13%
Both companies reducing D&A. Martin Whitman would check industry patterns.
22.28%
EBITDA growth while CRK declines. John Neff would investigate advantages.
-17.93%
EBITDA margin decline while CRK shows 127.01% growth. Joel Greenblatt would examine position.
42.63%
Operating income growth while CRK declines. John Neff would investigate advantages.
44.36%
Operating margin growth while CRK declines. John Neff would investigate advantages.
80.01%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
672.11%
Pre-tax income growth while CRK declines. John Neff would investigate advantages.
679.03%
Pre-tax margin growth while CRK declines. John Neff would investigate advantages.
556.64%
Tax expense growth while CRK reduces burden. John Neff would investigate differences.
1968.89%
Net income growth while CRK declines. John Neff would investigate advantages.
1991.52%
Net margin growth while CRK declines. John Neff would investigate advantages.
2385.71%
EPS growth while CRK declines. John Neff would investigate advantages.
2450.00%
Diluted EPS growth while CRK declines. John Neff would investigate advantages.
-19.18%
Share count reduction while CRK shows 13.61% change. Joel Greenblatt would examine strategy.
-18.90%
Diluted share reduction while CRK shows 6.44% change. Joel Greenblatt would examine strategy.